2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling (vol 471, pg 135, 2020)

被引：1
|
作者：
Yue, Yangyang [1 ]
Qian, Weikun [1 ]
Li, Jie [1 ]
Wu, Shiqi [2 ]
Zhang, Mengzhao [1 ,2 ]
Wu, Zheng [1 ]
Ma, Qingyong [1 ]
Wang, Zheng [1 ]
机构：
[1] Xi An Jiao Tong Univ, Dept Hepatobiliary Surg, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Urol Surg, Affiliated Hosp 1, Xian 710061, Shaanxi, Peoples R China
来源：
CANCER LETTERS | 2022年 / 549卷
关键词：
D O I：
10.1016/j.canlet.2022.215913
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling (vol 471, pg 135, 2020)
    Yue, Yangyang
    Qian, Weikun
    Li, Jie
    Wu, Shiqi
    Zhang, Mengzhao
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    CANCER LETTERS, 2024, 583
  • [2] 2′-Hydroxyflavanone inhibits the progression of pancreatic cancer cells and sensitizes the chemosensitivity of EGFR inhibitors via repressing STAT3 signaling
    Yue, Yangyang
    Qian, Weikun
    Li, Jie
    Wu, Shiqi
    Zhang, Mengzhao
    Wu, Zheng
    Ma, Qingyong
    Wang, Zheng
    CANCER LETTERS, 2020, 471 : 135 - 146
  • [3] Alantolactone sensitizes human pancreatic cancer cells to EGFR inhibitors through the inhibition of STAT3 signaling
    Zheng, Hailun
    Yang, Lehe
    Kang, Yanting
    Chen, Min
    Lin, Shichong
    Xiang, Youqun
    Li, Caleb
    Dai, Xuanxuan
    Huang, Xiaoying
    Liang, Guang
    Zhao, Chengguang
    MOLECULAR CARCINOGENESIS, 2019, 58 (04) : 565 - 576
  • [4] Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Lehe Yang
    Shichong Lin
    Yanting Kang
    Youqun Xiang
    Lingyuan Xu
    Jifa Li
    Xuanxuan Dai
    Guang Liang
    Xiaoying Huang
    Chengguang Zhao
    Journal of Experimental & Clinical Cancer Research, 38
  • [5] Rhein sensitizes human pancreatic cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Yang, Lehe
    Lin, Shichong
    Kang, Yanting
    Xiang, Youqun
    Xu, Lingyuan
    Li, Jifa
    Dai, Xuanxuan
    Liang, Guang
    Huang, Xiaoying
    Zhao, Chengguang
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [6] Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
    Jiang, Yafei
    Wang, Gangyang
    Mu, Haoran
    Ma, Xiaojun
    Wang, Zhuoying
    Lv, Yu
    Zhang, Tao
    Xu, Jing
    Wang, Jinzeng
    Li, Yunqi
    Han, Jing
    Yang, Mengkai
    Wang, Zongyi
    Zeng, Ke
    Jin, Xinmeng
    Xue, Song
    Yin, Mingzhu
    Sun, Wei
    Hua, Yingqi
    Cai, Zhengdong
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] 2-HF Sensitizes Human Pancreatic Cancer Cells to EGFR Inhibitors by Inhibiting STAT3 Pathway
    Dong, S. B.
    Yue, Y. Y.
    Ma, Q. Y.
    Wu, Z.
    Wang, Z.
    PANCREAS, 2019, 48 (10) : 1420 - 1420
  • [8] Emodin sensitizes human pancreatic cancer cells to EGFR inhibitor through suppressing Stat3 signaling pathway
    Wang, Zhaohong
    Chen, Hui
    Chen, Jingjing
    Hong, Zhong
    Liao, Yi
    Zhang, Qiyu
    Tong, Hongfei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 8463 - 8473
  • [9] Rhein sensitizes human colorectal cancer cells to EGFR inhibitors by inhibiting STAT3 pathway
    Zhuang, Yan
    Bai, Ying
    Hu, Yan
    Guo, Yueqin
    Xu, Lingyuan
    Hu, Wanle
    Yang, Lehe
    Zhao, Chengguang
    Li, Xiaokun
    Zhao, Haiyang
    ONCOTARGETS AND THERAPY, 2019, 12 : 5281 - 5291
  • [10] GRIM-19 inhibits the STAT3 signaling pathway and sensitizes gastric cancer cells to radiation
    Bu, Xianmin
    Zhao, Chenghai
    Wang, Wei
    Zhang, Ning
    GENE, 2013, 512 (02) : 198 - 205
12345